Case number 2016-1752
Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 13, 2016 | 19 | ORDER filed. The motion [18] is granted. The appeal is dismissed. Each side shall bear its own costs. ISSUED AS A MANDATE: December 13, 2016. Service: 12/13/2016 by clerk. [390403] [LMS] [Entered: 12/13/2016 10:50 AM] (2) |
| Dec 6, 2016 | 17 | Notice of Deficiency to Appellants Purdue Pharma, L.P., et al - the following document(s): motion to deactivate appeal [16] is REJECTED for filing. Reason(s): the incorrect ECF motion relief (deactivate appeal) was selected. PLEASE RE-FILE the motion using the relief "Case Termination". Service: 12/06/2016 by clerk. [Note: this entry is text only. no pdf is attached]. [388413] [AT] [Entered: 12/06/2016 08:50 AM] (0) |
| Dec 6, 2016 | 18 | MOTION of Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc. to terminate appeal through dismissal. [Consent: unopposed]. Service: 12/06/2016 by email. [388452] [Jennifer Swize] [Entered: 12/06/2016 09:39 AM] (5) |
| Dec 5, 2016 | 16 | MOTION of Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc. to deactivate appeal. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/05/2016 by email. [388366] [Jennifer Swize] [Entered: 12/05/2016 05:22 PM] (5) |
| Nov 28, 2016 | 15 | Status report for Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 11/28/2016 by email. [386478] [Jennifer Swize] [Entered: 11/28/2016 06:34 PM] (5) |
| May 2, 2016 | 14 | ORDER filed. The motion [13] is granted to the extent that the above-captioned appeal is stayed. The parties are directed to inform the court within 14 days after all appeal rights in Appeal No. 14-1294 have been exhausted how they believe this appeal should proceed. Service: 05/02/2016 by clerk. [331164] [LMS] [Entered: 05/02/2016 02:04 PM] (2) |
| Apr 22, 2016 | 13 | MOTION of Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc. to stay appeal. Response/Opposition is due 05/05/2016, to terminate appeal through dismissal without prejudice to reinstatement. [Consent: unopposed]. Service: 04/22/2016 by email. [329055] [Jennifer Swize] [Entered: 04/22/2016 06:15 PM] (10) |
| Apr 8, 2016 | 12 | Transcript Purchase Order Form for the Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc. indicating that a transcript is already on file. Service: 04/08/2016 by email. [325156] [Jennifer Swize] [Entered: 04/08/2016 02:36 PM] (2) |
| Apr 5, 2016 | 11 | Docketing Statement for the Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 04/05/2016 by email. [324073] [Jennifer Swize] [Entered: 04/05/2016 02:14 PM] (4) |
| Mar 28, 2016 | 7 | Entry of appearance for Gregory A. Castanias as principal counsel for Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/28/2016 by email. [322225] [Jennifer Swize] [Entered: 03/28/2016 04:11 PM] (2) |
| Mar 28, 2016 | 8 | Entry of appearance for John J. Normile as of counsel for Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/28/2016 by email. [322227] [Jennifer Swize] [Entered: 03/28/2016 04:12 PM] (2) |
| Mar 28, 2016 | 9 | Entry of appearance for Jennifer L. Swize as of counsel for Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/28/2016 by email. [322228] [Jennifer Swize] [Entered: 03/28/2016 04:14 PM] (2) |
| Mar 28, 2016 | 10 | Certificate of Interest for the Appellants Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/28/2016 by email. [322230] [Jennifer Swize] [Entered: 03/28/2016 04:15 PM] (2) |
| Mar 25, 2016 | 2 | Certificate of Interest for the Appellee Collegium Pharmaceutical, Inc.. Service: 03/25/2016 by email. [321865] [Jacob Holdreith] [Entered: 03/25/2016 03:41 PM] (2) |
| Mar 25, 2016 | 3 | Docketing Statement for the Appellee Collegium Pharmaceutical, Inc.. Service: 03/25/2016 by email. [321870] [Jacob Holdreith] [Entered: 03/25/2016 03:46 PM] (4) |
| Mar 25, 2016 | 4 | Entry of appearance for Jake M. Holdreith as principal counsel for Appellee Collegium Pharmaceutical, Inc.. Service: 03/25/2016 by email. [321872] [Jacob Holdreith] [Entered: 03/25/2016 03:48 PM] (2) |
| Mar 25, 2016 | 5 | Entry of appearance for Jamie R. Kurtz as of counsel for Appellee Collegium Pharmaceutical, Inc.. Service: 03/25/2016 by email. [321874] [Jacob Holdreith] [Entered: 03/25/2016 03:50 PM] (2) |
| Mar 25, 2016 | 6 | Entry of appearance for Kelsey J. Thorkelson as of counsel for Appellee Collegium Pharmaceutical, Inc.. Service: 03/25/2016 by email. [321876] [Jacob Holdreith] [Entered: 03/25/2016 03:52 PM] (2) |
| Mar 22, 2016 | 1 | Appeal docketed. Received: 03/21/2016. [320751]Entry of Appearance due 04/05/2016. Certificate of Interest is due on 04/05/2016. Docketing Statement due 04/05/2016. Appellant/Petitioner's brief is due 05/23/2016. [LN] [Entered: 03/22/2016 12:24 PM] (31) |
